Instituto Rosenbusch S.A. (BCBA:ROSE)

Argentina · Delayed Price · Currency is ARS

136.00

-2.50 (-1.81%)

At close: Nov 2, 2026

Market Cap	5.79B -7.2%
Revenue (ttm)	6.81B -19.5%
Net Income	183.57M
EPS	4.31
Shares Out	42.59M
PE Ratio	31.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,263
Open	141.50
Previous Close	138.50
Day's Range	135.00 - 142.00
52-Week Range	128.50 - 357.00
Beta	0.05
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 17, 2026

About Instituto Rosenbusch

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, i... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1917

Country Argentina

Stock Exchange Buenos Aires Stock Exchange

Ticker Symbol ROSE

Full Company Profile

Financial Performance

In 2025, Instituto Rosenbusch's revenue was 6.40 billion, a decrease of -41.17% compared to the previous year's 10.89 billion. Losses were -4.60 billion, 146.6% more than in 2024.

Financial Statements